2006
DOI: 10.1016/j.ymeth.2006.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Methods for the in vivo and in vitro analysis of [Het-s] prion infectivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
29
0
1

Year Published

2007
2007
2013
2013

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 26 publications
(30 citation statements)
references
References 17 publications
0
29
0
1
Order By: Relevance
“…Briefly, cells were lysed by sonication and the protein was extracted from the insoluble pellet fraction with 8 M guanidine-HCl, purified on a Talon (Clontech) column, and eluted in 8 M urea. Denaturant was removed using a HiTrap column GE Healthcare) in 175 mM acetic acid (37). The eluate containing 1.4 mM protein was neutralized with Tris base and incubated at 4°C without agitation for 7 days to allow fibril formation.…”
Section: Methodsmentioning
confidence: 99%
“…Briefly, cells were lysed by sonication and the protein was extracted from the insoluble pellet fraction with 8 M guanidine-HCl, purified on a Talon (Clontech) column, and eluted in 8 M urea. Denaturant was removed using a HiTrap column GE Healthcare) in 175 mM acetic acid (37). The eluate containing 1.4 mM protein was neutralized with Tris base and incubated at 4°C without agitation for 7 days to allow fibril formation.…”
Section: Methodsmentioning
confidence: 99%
“…The purified material was then used to infect prion-free P. anserina strains by using a protein transfection method as previously described. [16] While insoluble extracts from an E. coli control strain containing only the empty vector or IBs of a different protein (human NDP kinase) did not induce the appearance of the prion form [Het-s] (Table 1), strains transfected with HET-s(218-289) IBs acquired [Het-s] at a frequency comparable to or even higher than that found for transfection with HET-s(218-289) amyloids assembled in vitro. We conclude Next, a set of experiments was performed in which further properties of the HET-s IBs and amyloid fibrils assembled in vitro were compared.…”
mentioning
confidence: 95%
“…Herein we describe a structural and functional characterization of HET-s(218-289) IBs produced in E. coli by using electron microscopy (EM), NMR spectroscopy to determine H/D exchange, solid-state NMR spectroscopy, and in vivo prion infectivity assays as described earlier. [16] HET-s(218-289) was expressed in E. coli cells and located as typical angular-shaped inclusions with high electron density and a cross-section of 100-400 nm preferentially at the cellular poles ( Figure 1 and Figure S1 in the Supporting Information). The IBs were partially purified (see the Supporting Information) and this material was shown by EM (Figure 1 b) to consist of fibrillar structures.…”
mentioning
confidence: 99%
“…Die IBs wurden teilweise gereinigt (Hintergrundinformationen), woraufhin in weiteren EM-Bildern (Abbildung 1 b) bereits fibrilläre Strukturen sichtbar wurden. Das gereinigte Material wurde auch verwendet, um prionenfreie P.-anserina-Stämme mithilfe einer Protein-Transfektionsmethode [16] zu infizieren. Während unlösliche Extrakte von E.-coli-Kontrollstämmen, die nur einen leeren Vektor oder IBs eines anderen Proteins [9,17] Außerdem verhalten sich die HET-s(218-289)-IBs und -Amyloide bei chemischer Denaturierung ähnlich: Beide sind im neutralen pH-Bereich, jedoch nicht bei pH 2 resistent gegen Denaturierung durch Harnstoff (Abbildung S2B, Hintergrundinformationen).…”
unclassified